Eli Lilly Victorious in Case Against Med Spa for Selling Fake Diabetes/Weight Loss Drugs

May 16, 2024 |

Eli Lilly entered into a settlement agreement with Totality Medispa for monetary payment and to halt further sale of unapproved versions of the company’s monumental Type 2 diabetes and weight loss drugs, Mounjaro and Zepbound (tirzepatide).
Source: Drug Industry Daily